Portfolio (Quarterly)
Guide ↗
Rhenman & Partners Asset Management AB
· CIK 0001599882| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | 139,205.0 | $16.3M | 1.54% | +47K | +50.3% | $117.07 | -17.1% |
| 22 | INSM | INSMED INC | Healthcare | 151,960.0 | $16.2M | 1.53% | -8K | -4.9% | $106.62 | +17.3% |
| 23 | THC | TENET HEALTHCARE CORP | Healthcare | 85,200.0 | $15.9M | 1.50% | +31K | +57.8% | $187.08 | +45.7% |
| 24 | TMO | THERMO FISHER SCIENTIFIC INC | Healthcare | 31,580.0 | $15.8M | 1.49% | -10K | -23.6% | $501.36 | +25.2% |
| 25 | CNC | CENTENE CORP DEL | Healthcare | 244,000.0 | $15.7M | 1.48% | NEW | — | $64.19 | -0.1% |
| 26 | AXSM | AXSOME THERAPEUTICS INC. | Healthcare | 63,050.0 | $15.4M | 1.46% | -750.0 | -1.2% | $244.77 | -15.0% |
| 27 | DHR | DANAHER CORPORATION | Healthcare | 80,252.0 | $15.3M | 1.44% | +62K | +344.6% | $190.48 | +13.4% |
| 28 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 30,685.0 | $15.2M | 1.44% | -13K | -29.4% | $496.73 | +8.8% |
| 29 | — | ANTERIS TECHNOLOGIES GLOBAL | — | 1,538,625.0 | $15.2M | 1.43% | +100K | +7.0% | $9.85 | — |
| 30 | NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | 85,841.0 | $14.5M | 1.37% | -15K | -14.9% | $168.53 | -9.3% |
| 31 | PNTG | PENNANT GROUP INC | Healthcare | 371,471.0 | $13.7M | 1.30% | +96K | +34.9% | $36.95 | +5.5% |
| 32 | ISRG | INTUITIVE SURGICAL INC | Healthcare | 34,500.0 | $13.7M | 1.29% | -2K | -6.4% | $397.68 | -5.8% |
| 33 | ELV | ELEVANCE HEALTH INC | Healthcare | 34,900.0 | $13.5M | 1.27% | +3K | +8.1% | $386.73 | +2.5% |
| 34 | LIVN | LIVANOVA PLC | Healthcare | 164,000.0 | $13.5M | 1.27% | +9K | +5.8% | $82.23 | -4.9% |
| 35 | — | CENCORA INC | — | 46,778.0 | $13.2M | 1.25% | -6K | -10.7% | $282.98 | — |
| 36 | CRL | CHARLES RIV LABS INTL INC | Healthcare | 57,200.0 | $13.0M | 1.22% | +31K | +120.0% | $226.79 | +28.5% |
| 37 | IDYA | IDEAYA Biosciences Inc | Healthcare | 343,800.0 | $12.8M | 1.21% | +88K | +34.6% | $37.27 | +4.9% |
| 38 | MCK | MCKESSON CORP | Healthcare | 16,550.0 | $12.5M | 1.18% | -300.0 | -1.8% | $755.60 | +11.0% |
| 39 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 560,250.0 | $12.2M | 1.16% | +181K | +47.7% | $21.86 | -9.7% |
| 40 | BTSG | BRIGHTSPRING HEALTH SVCS INC | Healthcare | 165,896.0 | $11.6M | 1.09% | +116K | +231.8% | $69.74 | -14.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.6%
Technology
0.4%